Sonoma Pharmaceuticals, Inc. SNOA

Set alert

Price alert · SNOA

All alert types
1.10 USD 0.00 0.00%

At close · Nov 2

1.07 -0.03 -2.64%

After hours · Nov 2, 4:00 PM ET

Bid
1.10 × 2
Ask
1.12 × 2
1.05 Day range 1.15
0.85 52-week range 3.97
YTD
-69.78%
1 year
-72.08%
Open
1.08
Prev close
1.10
Mkt cap
5.27M
Vol
42.24K
Avg vol
107.76K
EPS
-1.22
P/E
0.00
Div yield
0.00%
More statistics
Low
1.05
High
1.15
Forward P/E
-1.49
Beta
1.38
Short ratio
0.22
Inst. own
2.42%
Dividend
0.00
Ex-div date
Earnings
Feb 13, 2025
50-d avg
2.82
200-d avg
3.79
1y target
19.50

5D chart

Chart tools
Interval

Signals (15)
NameTimeAgo
SMA: BullishNov 2, 3:55 PM14 hours ago
SMA: BullishNov 2, 3:55 PM14 hours ago
SMA: BearishNov 2, 3:45 PM14 hours ago
MACD: Buy SignalNov 2, 2:45 PM15 hours ago
SMA: BearishNov 2, 11:50 AM18 hours ago
SMA: BullishNov 2, 11:20 AM19 hours ago
RSI: OversoldNov 2, 9:30 AM20 hours ago
SMA: BearishOct 30, 9:30 AM3 days ago
MACD: Sell SignalOct 30, 9:30 AM3 days ago
MACD: Buy SignalOct 29, 3:55 PM4 days ago
MACD: Sell SignalOct 29, 2:30 PM4 days ago
SMA: BullishOct 29, 9:35 AM4 days ago
SMA: BearishOct 28, 3:55 PM5 days ago
RSI: OverboughtOct 28, 3:05 PM5 days ago
SMA: BearishOct 28, 9:30 AM5 days ago

Analyst view

Consensus: none

Price target (mean) 19.50 +1672.7% upside
Target (low)
17.00
Target (mean)
19.50
Target (high)
22.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

SNOA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.60-0.60 – -0.600.000.0%4.06M+29.4%1
Next quarter-0.60-0.60 – -0.600.000.0%4.44M+29.1%1
Current year-2.80-2.80 – -2.800.000.0%15.47M+21.5%1
Next year-1.20-1.20 – -1.20-2.80+57.1%19.67M+27.2%1

Upgrades and downgrades

The latest rating changes

SNOA analyst upgrades and downgrades
DateFirmActionFromTo
Sep 5, 2023Ladenburg ThalmannInitiated—Buy
Mar 6, 2018Maxim GroupDowngradeBuyHold
Dec 28, 2017BenchmarkInitiated—Speculative Buy
Nov 10, 2017Maxim GroupMaintained—Buy